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Stem cell research is of high interest, be-
cause precursor cells can be directed to dif-
ferentiate into practically all mature cell 
types. This represents a potential perspective 
for therapeutics of severely damaged organs 
and also an alternative to animal drug and 
toxicity testing. Nonetheless, an essential 
question still remains: How similar are dif-
ferentiated stem cells to the desired mature 
cells, e.g. liver cells? This highlight report 
focusses on a study recently published in the 
Journal of Hepatology (Godoy et al., 2013) 
where three European research centers de-
veloped a method for precisely assessing the 
degree of stem cell-differentiation into 
hepatocytes based on whole-genome gene 
expression analysis and statistical models. 
The liver has a spectacular ability to re-
generate (Hoehme et al., 2010; Drasdo et al., 
2014; Schliess et al. 2014, Nussler et al., 
2014). However, this capacity is compro-
mised after severe acute damage or in chron-
ic disease such as cirrhosis. In these situa-
tions, the only solution up to now is organ 
transplantation, which comes often too late 
and implies high risks for the patients. Scien-
tists around the world are working on a 
promising alternative: stem cell therapy 
(Brulport et al., 2007). In principle, stem 
cells have the capacity to differentiate into 
every cell of the human body – skin, neu-
ronal cells or hepatocytes. However, the de-
gree of similarity between stem cell-derived 
tissue cells (for example, hepatocyte-like 
cells) and primary hepatocytes is still con-
troversial (Godoy et al., 2013; Hengstler et 
al., 2005). This is a very important issue, be-
cause the application of these cells for thera-
peutic or toxicity testing requires that they 
perform all functions of a mature tissue. 
Recently Godoy et al. (2015) developed a 
method for comparing hepatocyte-like cells 
and original (primary) human hepatocytes 
based on their gene expression profiles. Giv-
en the high number of genes, approximately 
22.000, in the human genome, this compari-
son is not an easy task. The authors clustered 
the thousands of genes according to special 
functions and regulatory principles by apply-
ing mathematical models. For example, 
some genes are responsible for the expres-
sion of proteins involved in metabolism, 
while others regulate cell proliferation. Par-
ticularly relevant for hepatocytes are cyto-
chrome P450 enzymes and phase II metabo-
lizing enzymes, because they decompose 
toxic substances – a main task of the liver. 
On the other hand, genes regulating the cell 
cycle are less relevant because hepatocytes 
do not proliferate at a high rate in a healthy 
liver (Zellmer et al., 2010).  
The authors applied biostatistical tech-
niques to compare gene clusters using real 
liver cells (primary human hepatocytes), 
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stem cells and six different stem cell-derived 
hepatocyte-like cells (Godoy et al., 2015). 
The comparison shows that in some gene 
clusters hepatocyte-like cells are very similar 
to primary hepatocytes, including many 
genes involved in drug and xenobiotic me-
tabolism. Surprisingly, other gene clusters in 
HLC indicate that these cells acquire proper-
ties of additional tissues, including colon and 
fibroblasts. Importantly, the analysis re-
vealed the mechanisms and transcription fac-
tors responsible for the expression of genes 
associated with each tissue type. This ap-
proach allows to precisely determine the ex-
tent of differentiation from stem cells, the 
degree of acquisition of liver features and the 
appearance of undesired additional tissue 
types. 
The study of Godoy et al. (2015) repre-
sents an important step towards a more pre-
cise and unbiased determination, to which 
degree stem cell derived cells resemble pri-
mary cells. Furthermore, since cultivated liv-
er cells are a basic tool for testing the effects 
of new medicinal drugs, hepatocyte-like cells 
can become an important alternative to ani-
mal testing (Ghallab et al., 2013, 2014a, b). 
Currently such alternative in vitro systems 
play a major role in testing of neurotoxicity 
(Waldmann et al., 2014; Zimmer et al., 2014; 
Krug et al., 2013), nephrotoxicity (Faiz et al., 
2015; Yang et al., 2014) and hepatotoxicity 
(Heise et al., 2012; Godoy et al., 2009; Go-
doy 2011; Godoy and Bolt, 2012; Grinberg 
et al., 2014; Hengstler et al., 2000). The re-
sults are also important, because medicinal 
and toxic substances are currently being test-
ed with hepatocyte-like cells, and now it be-
comes possible to determine how trustwor-
thy the results can be. 
This is the first time that such a systemat-
ic genome wide comparison of stem cell de-
rived and genuine hepatocytes has been per-
formed. The recent published study in the 
Journal of Hepatology (Godoy et al., 2015) 
offers a blueprint for research in stem cell 
differentiation of liver cells. 
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